Trial Outcomes & Findings for SpO2 System Accuracy Testing With Different Sensors (NCT NCT01613222)
NCT ID: NCT01613222
Last Updated: 2019-02-05
Results Overview
The Accuracy Root Mean Square (ARMS) calculation is used to measure accuracy of the test SpO2 device compared to reference SpO2 device. A scatterplot is created with the forehead sensor saturation on the y-axis and the measured blood saturation on the x-axis. The line of identity is drawn representing the ideal points, meaning that the forehead sensor saturation is always the same as the blood saturation. The dispersion of the actual data points around the line of identity can be measured using a statistical calculation called Arithmetic Root Mean Square (ARMS). The smaller ARMs the closer the data points lie around the line of identity, representing a more accurate sensor as accurate and appropriate. Data analysis follows ISO 80601-2-61, 2011, Annex EE and the FDA Guidance Document for Pulse Oximeters (FDA Draft Guidance, July 19, 2007).
COMPLETED
NA
63 participants
60 minutes
2019-02-05
Participant Flow
The first subject was enrolled on June19, 2012 and the last subject was enrolled on February 15, 2013. The study was conducted at Clinimark, a human performance laboratory that tests physiological monitoring devices.
Participant milestones
| Measure |
Pulse Oximetry Monitoring
Pulse oximetry : Pulse oximetry measurement using SpO2 sensors, patient monitors, co-oximeters, and various modules.
|
|---|---|
|
Overall Study
STARTED
|
63
|
|
Overall Study
COMPLETED
|
51
|
|
Overall Study
NOT COMPLETED
|
12
|
Reasons for withdrawal
| Measure |
Pulse Oximetry Monitoring
Pulse oximetry : Pulse oximetry measurement using SpO2 sensors, patient monitors, co-oximeters, and various modules.
|
|---|---|
|
Overall Study
Physician Decision
|
1
|
|
Overall Study
Unable to place arterial line
|
1
|
|
Overall Study
Reused disposable sensors
|
10
|
Baseline Characteristics
SpO2 System Accuracy Testing With Different Sensors
Baseline characteristics by cohort
| Measure |
Pulse Oximetry Monitoring
n=51 Participants
Pulse Oximetry Monitoring Single Arm
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
51 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
|
Age, Continuous
|
23.4 years
STANDARD_DEVIATION 3.8 • n=5 Participants
|
|
Sex: Female, Male
Female
|
28 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
23 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
51 participants
n=5 Participants
|
|
SpO2
|
95.1 % oxygen
STANDARD_DEVIATION 1.6 • n=5 Participants
|
PRIMARY outcome
Timeframe: 60 minutesPopulation: The data analyzed was SpO2 data pairs using different U-Trusginal SpO2 sensors, patient monitors, co-oximeters, and various modules. Multiple data pairs were collected from each study participant, but not all sensors, patient monitors, co-oximeters and module configurations were used with each participant.
The Accuracy Root Mean Square (ARMS) calculation is used to measure accuracy of the test SpO2 device compared to reference SpO2 device. A scatterplot is created with the forehead sensor saturation on the y-axis and the measured blood saturation on the x-axis. The line of identity is drawn representing the ideal points, meaning that the forehead sensor saturation is always the same as the blood saturation. The dispersion of the actual data points around the line of identity can be measured using a statistical calculation called Arithmetic Root Mean Square (ARMS). The smaller ARMs the closer the data points lie around the line of identity, representing a more accurate sensor as accurate and appropriate. Data analysis follows ISO 80601-2-61, 2011, Annex EE and the FDA Guidance Document for Pulse Oximeters (FDA Draft Guidance, July 19, 2007).
Outcome measures
| Measure |
Pulse Oximetry Monitoring Using SpO@ Sensors
n=2826 Number of Data Pairs
Pulse oximetry measurement using different U-Trusginal SpO2 sensors, patient monitors, co-oximeters, and various modules.
|
|---|---|
|
Accuracy Root Mean Square (ARMS)
TS-AAW Sensor + B40 Patient Monitor
|
1.488 Accuracy Root Mean Square
Interval -3.875 to 4.55
|
|
Accuracy Root Mean Square (ARMS)
TS-AAW Sensor + 3900 Oximeter
|
1.465 Accuracy Root Mean Square
Interval -4.58 to 4.41
|
|
Accuracy Root Mean Square (ARMS)
TS-AAW Sensor + Carescape V100 & UTrusignal V2
|
1.651 Accuracy Root Mean Square
Interval -3.5 to 7.1
|
|
Accuracy Root Mean Square (ARMS)
TS-AAW Sensor + Carescape V100
|
1.352 Accuracy Root Mean Square
Interval -5.175 to 5.0
|
|
Accuracy Root Mean Square (ARMS)
TS-AAW Sensor + EPRESTN
|
2.179 Accuracy Root Mean Square
Interval -7.005 to 8.42
|
|
Accuracy Root Mean Square (ARMS)
TS-AAW Sensor + M-NESTPR
|
1.813 Accuracy Root Mean Square
Interval -7.7 to 3.65
|
|
Accuracy Root Mean Square (ARMS)
TS-AAW Sensor + M-OSAT
|
1.496 Accuracy Root Mean Square
Interval -2.9 to 4.55
|
|
Accuracy Root Mean Square (ARMS)
TS-AAW Sensor + TruSat
|
1.612 Accuracy Root Mean Square
Interval -4.865 to 7.71
|
|
Accuracy Root Mean Square (ARMS)
TS-SA-D Sensor + TruSat
|
1.523 Accuracy Root Mean Square
Interval -3.65 to 7.07
|
|
Accuracy Root Mean Square (ARMS)
TS-AAW Sensor + TruffSat
|
1.286 Accuracy Root Mean Square
Interval -3.275 to 4.55
|
Adverse Events
TS-AAW Sensor + 3900 Oximeter
TS-AAW Sensor + B40 Patient Monitor
TS-AAW Sensor + Carescape V100 With TruSignal V2 SpO2 Board
TS-AAW Sensor + Carescape V100
TS-AAW Sensor + EPRESTN
TS-AAW Sensor + M-NESTPR
TS-AAW Sensor + M-OSAT
TS-AAW Sensor + TruSat
TS-AAW Sensor + TuffSat
TS-SA-D Sensor + Carescape V100 With TruSignal V2 SpO2 Board
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee The sponsor cannot require changes to the PI's disclosure, with the exception of requesting the removal of sponsor's confidential information. The study results themselves are not considered confidential information. Sponsor cannot extend the embargo beyond 60 days unless the PI's disclosure contains patentable subject matter, in which an embargo beyond 60 days may be necessary to allow for the filing of a patent application
- Publication restrictions are in place
Restriction type: OTHER